Keywords: innate, raises, 15m, euros, intermediate, financing, france

Innate raises 15M euros in intermediate financing

Article | 09 August 2004

France's Innate Pharma SAS, a biopharmaceutical company specialized ininnate immunity, announces today that it has raised 15 million euros ($18.2 million) in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Novo Nordisk

Delta T

Go to company listing